Beta: Sign in
Shares outstandingAs of 2026-07-31 · filed common shares: 30.25M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 32.75%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 5.99%
Short ratioDays to cover, as published by FINRA: 13.38
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 64.60%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 61.30%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Loading evidence for RNAC

Rev growth (fwd)

Avg volume (3 months)

Profitability

Gross margin: —
Operating marginTTM to Jun 26: -10518.55%
Net margin: —
EBITDA marginTTM to Jun 26: -10282.67%
Return on equity: —
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: -42.94%

Growth

Revenue growth (annual YoY): -92.81%
Revenue growth (latest qtr YoY): -100.00%
Revenue growth (fwd): Sign in
Net income growth (annual YoY): —
Net income growth (latest qtr YoY): -0.74%
EPS growth (fwd): Sign in
Net income growth (QoQ): —

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales: Sign in
Price / operating cash flow: Sign in
P/FCF: Sign in
EV / revenue: Sign in
EV / EBITDA: Sign in
EPSDiluted, TTM to Jun 26: -5.78
EPS (fwd): Sign in

Financial health

Cash & equivalentsas of Jun 26: $147.60M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $63.85M
Debt / equityas of Jun 26: -50.99%
Current ratioas of Jun 26: 7.48
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Jun 26: 7.19
Operating cash flowTTM to Jun 26: -$76.52M
Free cash flowUnadjusted FCF = CFO − capex · TTM to Jun 26: -$78.61M
TTM revenue / diluted shareDiluted, TTM to Jun 26: 0.05

RNAC stock Statistics — Cartesian Therapeutics, Inc. filings, insiders & smart money · Instaport